Det firma, der fremstiller Glivec, vil foretage yderligere undersøgelser af Glivec, herunder dets vek - selvirkning med andre lægemidler, dets indvirkning på resultatet af fremtidige knoglemarvstransplan - tationer og dets virkning hos patienter med GIST, navnlig ved høje doser.
The company that makes Glivec will carry out further studies into Glivec, including an examination of its interactions with other medicines, its effects on the outcome of future bone marrow transplants and its effectiveness in patients with GIST, particularly at high dosages.